- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Molecules publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Mechanism and Modulation in Radiotoxicity
Deadline: 31 May 2026
Updates on Tissue Repair and Regeneration Pathways
Deadline: 31 May 2026
Advances in Liver Oncology: Molecular Mechanisms and Therapeutic Innovations
Deadline: 31 May 2026
Past, Present and Further Looking for Therapeutic Management of Pancreatic Ductal Adenocarcinoma (2nd Edition)
Deadline: 31 May 2026
Poly-Pharmacological Effects and Mechanisms of Phytochemicals
Deadline: 31 May 2026
Tumor Biomarkers in Gynecology—2nd Edition
Deadline: 31 May 2026
Exploring Conventional and Alternative Animal Models in Biomedical Research (Biomedicines)
Deadline: 31 May 2026
Osteoarthritis: Molecular Pathways and Novel Therapeutic Strategies—2nd Edition
Deadline: 31 May 2026
Pathogenesis and Targeted Therapy of Autoimmune Diseases
Deadline: 31 May 2026
Advances in Therapeutic Strategies and Precision Medicine in Solid Tumors and Metastasis—2nd Edition
Deadline: 31 May 2026
Advances Research on Nanomedicine
Deadline: 31 May 2026
Immunotherapy and Targeted Treatment in Solid Tumors: Biomarkers and Novel Therapeutic Strategies
Deadline: 31 May 2026
of 148

